Michigan, like many states, faces rising healthcare costs that necessitate thoughtful policy interventions.

While Michigan boasts some of the nation’s lowest commercial healthcare prices and a relatively low uninsured rate of just 6%, challenges remain, such as rising individual premiums, now averaging $7,300, and a market dominated by a few major health plans and providers.

Forthcoming legislation, including a promising prescription drug affordability board, highlights Michigan’s proactive stance on healthcare cost management. The action on prescription drug affordability can open the door to more comprehensive measures needed to address escalating health care prices more broadly,  beyond prescription drugs.

“State of Healthcare: Policy Considerations to Constrain Commercial Prices – Michigan” offers a deep dive into Michigan’s unique healthcare environment through the perspectives of eight key stakeholders, including healthcare purchasers, physicians, health plan representatives, and industry experts. This report and accompanying executive summary assesses their views on the current pricing strategies and explores their support for potential policies aimed at further constraining healthcare prices.

This analysis sheds light on the key issues facing Michigan’s healthcare system and outlines three actionable policy solutions aimed at tackling these challenges.

Complete the form below to access the full report. The Executive Summary does not require personal information for download and can be accessed at the bottom of this page.

Download the Executive Summary for this report by clicking below. Executive Summary does not require entering personal information to download.